AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
(From AFX UK (Focus))
MUMBAI (Thomson Financial) - Moody's Investors Service placed the ratings of Inverness Medical Innovations Inc on review for possible downgrade after the company agreed to buy the remaining 95.3 pct of Biosite Inc for 90 usd a share.
The ratings include Inverness' B2 corporate family rating, B2 probability of default rating and Caa1 rating on 150 mln usd of senior subordinated notes due 2012.
The review …